Insulet
PODDAlgoritmens signaler
- ›Pris under både MA50 och MA200 (svag trend)
- ›-48% från 52v-toppen
- ›Svagt 3m-momentum (-31.0%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsDiabetes device maker Insulet to webcast May 13 investor talk - Stock Titan
1 d sedanDiabetes device maker Insulet to webcast May 13 investor talk Stock Titan
Stock TitanInsulet to Participate in BofA Securities 2026 Health Care Conference - ChartMill
1 d sedanInsulet to Participate in BofA Securities 2026 Health Care Conference ChartMill
ChartMillInsulet (PODD) down 8.2% since last earnings report: Can it rebound? - MSN
1 d sedanInsulet (PODD) down 8.2% since last earnings report: Can it rebound? MSN
MSNInsulet (NASDAQ:PODD) Rating Lowered to "Hold" at Rothschild & Co Redburn - MarketBeat
4 d sedanInsulet (NASDAQ:PODD) Rating Lowered to "Hold" at Rothschild & Co Redburn MarketBeat
MarketBeatINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
2026-04-09INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD PR Newswire NEW YORK, April 9, 2026 NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LL
InsuletPR NewswireAnalysts See 75% Upside on Insulet Corporation (PODD) Despite Weak Share Price Momentum - Yahoo Finance
2026-04-09Analysts See 75% Upside on Insulet Corporation (PODD) Despite Weak Share Price Momentum Yahoo Finance
Yahoo FinancePODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky
2026-03-25PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky PR New
InsuletPR NewswireInsulet Stock Drops 7% After Omnipod 5 Recall - TIKR.com
2026-03-16Insulet Stock Drops 7% After Omnipod 5 Recall TIKR.com
TIKR.comIs 14.8% Fall In Insulet (PODD) Stock A Buying Opportunity? - Trefis
2026-03-14Is 14.8% Fall In Insulet (PODD) Stock A Buying Opportunity? Trefis
TrefisInsulet Reports Third Quarter 2025 Results
2025-11-06Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the th
InsuletBusinesswireInsulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
2025-10-30Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its new campaign, “The Day Diabe
InsuletBusinesswireInsulet Announces Appointment of Robert L. Huffines to its Board of Directors
2025-10-23Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Robert (“Robb
InsuletBusinesswireInsulet to Host Investor Day on November 20, 2025
2025-10-10Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton
InsuletBusinesswireInsulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
2025-09-18Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Pantone®, the global authority on color and
InsuletBusinesswireInsulet Announces CFO Transition
2025-09-16Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succe
InsuletBusinesswireInsulet Elevates Eric Benjamin to Chief Operating Officer
2025-08-25Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Eric Benjamin
InsuletBusinesswire